Dawson James News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Scheduled to Reverse Split on Monday, June 10th

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Free Report) shares are going to reverse split on the morning of Monday, June 10th. The 1-32 reverse split was announced on Thursday, June 6th. The number of shares owned by shareholders will be adjusted after the market closes on Friday, June 7th. Tonix Pharmaceuticals Price Performance Shares of […]

Zembrace symtouchDawson jamesTonix pharmaceuticals price performanceTonix pharmaceuticalsNews ratings for tonix pharmaceuticals dailyInstitutional trading of tonix pharmaceuticalsAcadian asset managementArmistice capitalSabby managementTonix pharmaceuticals holding corpTonix pharmaceuticals holdingFree reportGet free reportAsset managementPharmaceuticals holding corpTonix pharmaceuticals daily

StockNews com Initiates Coverage on Tonix Pharmaceuticals (NASDAQ:TNXP)

Equities researchers at StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a report issued on Wednesday. The brokerage set a “sell” rating on the stock. Separately, Dawson James began coverage on shares of Tonix Pharmaceuticals in a report on Wednesday, February 28th. They set a “buy” rating and a […]

Zembrace symtouchDawson jamesTonix pharmaceuticals company profileNews ratings for tonix pharmaceuticals dailyArmistice capitalHedge funds weigh in on tonix pharmaceuticalsSabby managementTonix pharmaceuticalsTonix pharmaceuticals holding corpTonix pharmaceuticals price performanceAcadian asset managementGet free reportAsset managementPharmaceuticals holding corpTonix pharmaceuticals daily

Tonix Pharmaceuticals (NASDAQ:TNXP) Coverage Initiated at StockNews com

StockNews.com initiated coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research note issued to investors on Tuesday. The brokerage issued a sell rating on the stock. Separately, Dawson James initiated coverage on Tonix Pharmaceuticals in a research report on Wednesday, February 28th. They set a buy rating and a $3.00 price […]

Dawson jamesZembrace symtouchInstitutional investors weigh in on tonix pharmaceuticalsTonix pharmaceuticals holding corpTonix pharmaceuticals price performanceTonix pharmaceuticalsArmistice capitalAcadian asset managementNews ratings for tonix pharmaceuticals dailySabby managementFree reportGet free reportAsset managementPharmaceuticals holding corpTonix pharmaceuticals daily

Daré Bioscience (NASDAQ:DARE) Announces Earnings Results, Misses Expectations By $0 01 EPS

Daré Bioscience (NASDAQ:DARE) Announces Earnings Results, Misses Expectations By $0 01 EPS
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

United statesDawson jamesBioscience incBioscience company profileGet free reportBrookline capital managementBioscience companyBioscience daily

Tonix Pharmaceuticals (NASDAQ:TNXP) Research Coverage Started at StockNews com

Tonix Pharmaceuticals (NASDAQ:TNXP) Research Coverage Started at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Dawson jamesZembrace symtouchNews ratings for tonix pharmaceuticals dailyInstitutional trading of tonix pharmaceuticalsAcadian asset managementTonix pharmaceuticals holding corpSabby managementArmistice capitalTonix pharmaceuticalsTonix pharmaceuticals stock performanceFree reportGet free reportAsset managementPharmaceuticals holding corpTonix pharmaceuticals daily